From allusions in Alice in Wonderland to subject matter in Ted Talks, psychedelics are moving from pop culture parody toward mainstream medicine. What challenges does this evolution pose for the pharmaceutical community? Panelists will explore regulatory uncertainty, including psychedelics as a Schedule I drug and efficacy; patient safety data gaps; potential benefits of use; and cultural significance of psychedelics to many Indigenous people and the importance of those roots as psychedelics are developed for pharmaceutical purposes. 


Robert Haferd, Restorative Justice Coordinator, Office of the Attorney General of the District of Columbia
Karen Luong, Litigation Attorney, Husch Blackwell LLP
Suzanne Sisley, Adjunct Professor, Humboldt Institute for Interdisciplinary Marijuana Research, California State Polytechnic University
Moderated by Deborah Miran, DMiran Consulting


Member Price
Non-Member Price
Student Member Price




Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.


An access link will be provided to attendees via email upon registration.

If you are registering on behalf of someone else, the link to access the webinar will go to the email address provided at the point of registration.

Those registering on the day of the webinar will receive an access link via email upon successful payment.


We use Zoom to conduct webinars which works on most devices. You may participate in the webinar on a mobile device via the Zoom App or by dialing in. If you require the dial in information, please contact Maura Schatz at [email protected].

Test your device: https://support.zoom.us/hc/en-us/articles/201362193-Joining-a-meeting


Webinar recordings are sent via email as soon as we are able to process and verify the quality of the recording. This usually occurs within 3 business days of a webinar broadcast.

If multiple people at your organization wish to participate from separate devices, each will be required to purchase access.